ArticleTherapeutic advances in gastroenterology2021

Dynamics of serum concentrations of antibodies to infliximab: a new approach for predicting secondary loss of response in inflammatory bowel diseases.

Melina K Grasmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.